We wanted to provide a quick update on how PRESTIGE-AF is progressing at the moment in regard to COVID-19. To ensure the safety and well-being of all participants, the clinical steering committee and the sponsor of the prestige-AF trial have decided to temporarily suspend the recruitment of further participants. For those participants already enrolled in the trials, mitigating measures have been put in place and their safety and health is assured.
This is not a unique circumstance, many research programmes across Europe are also in similar situations and are impacted by the containment measures.
We are closely monitoring the situation and will provide another update when there are any changes.
For further information, the European Commission has placed up-to-date information on their website regarding COVID-19 response and action.
Prof Roland Veltkamp
Imperial College London
PRESTIGE-AF coordinator and on behalf of the PRESTIGE-AF consortium